The UK’s AstraZeneca, which is working on an oral GLP-1, also views the drugs as part of a combination strategy. In other ...

Obesity is a chronic complex relapsing disease defined by abnormal and/or excessive fat accumulation that presents a risk to ...

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

With obesity rates rising globally among both the adult and adolescent populations—contributing to chronic conditions like ...

Childhood obesity is on the rise in the US, with the CDC estimating approximately 1 in 5 children are living with obesity. 1 ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 ...

Almost a third (32%) of people with underlying health conditions such as respiratory disease, diabetes and morbid obesity ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...

Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).